New 3D wholebody PET imaging to detect metastatic renal cancer with 18F-FDG, Journal of Nuc1ear Medicine, vol.42, p.288, 2001. ,
Efficiency of [ 18 F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT, European Journal of Nuclear Medicine and Molecular Imaging, vol.30, issue.9 ,
DOI : 10.1007/s00259-003-1211-4
Tumor Burden Assessment with Positron Emission Tomography with [18 F]FDG. Clinical Positron Imagin g, pp.57-65, 2000. ,
Small renal cell carcin omas: resolving a diagn ostic dilemma, Radiolo gy, vol.166, pp.637-641, 1988. ,
Measurement of renal tumour and normal tissue perfusi on using positron emissi on tomography in a phase II clinical trial of razoxane, British Journal of Cancer Ju1, vol.21, issue.892, pp.262-269, 2003. ,
Positron emissi on tomography . Introduction of a new procedure in diagnosis of urologie tumors and initial clinical results . Urolo gy Annals, pp.138-180, 1995. ,
Positron emissi on tomography in diagnosis of renal cell carcin oma, UrQ1Qgy Annals, vol.35, pp.146-150, 1996. ,
Possible role of FDG-PET in the evaluation of urologie malignancies, Anticancer Research, vol.17, issue.3B, pp.1655-60, 1997. ,
Bilan préopératoire des cancers du rein en scanner volumique, Journal of Radio1ogy, vol.83, pp.431-50, 2002. ,
Clin ical l'ole of positron emission tomogra phy in oncology, Lancet Onco logy, vol.200, issue.2, pp.157-164 ,
Wh ole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-proline. Nuclear Medicine Bio1ogy, pp.287-92, 2001. ,
Utilisation de la tomographie par emission de positons au [18F]-FDG en cancérologie. Résultats dans les cancers urologiques, Bulletin du Cancer, pp.80-87, 2003. ,
Corstens FR 131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nuclear medicine comm unications, pp.229-265, 2002. ,
Zr-Labeled cG250 Monoclonal Antibody in Nude Rats, Cancer Biotherapy & Radiopharmaceuticals, vol.19, issue.2, pp.155-63, 2004. ,
DOI : 10.1089/108497804323071922
Differentiating Solitary Pulmonary Metastases in Patients with Renal Cell Carcinomas by <sup>18</sup>F-Fluoro-2-Deoxyglucose Positron Emission Tomography ??? A Preliminary Report, Urologia Internationalis, vol.71, issue.3, pp.306-315, 2003. ,
DOI : 10.1159/000072683
Large renal cell carcinoma isometabolic with normalliver on F -18 FDG PET scan. Clinical Nuclear Medi cine, Au g, vol.29, issue.8, pp.488-90, 2004. ,
Cancer du rein de l'adulte. Rapport du congrès de l'AFU 1997. Pro grammes d'Urologie, pp.723-909, 1997. ,
Rapport du congrès de l'AFU, 2000. ,
Imagerie du haut appareil urinaire de l'adulte. Masson éditions., Pari s ,
Visualisation of bladder cancer using (ll)C-cho lin e PET: first clinical experience, European Journal of Nuclear Medicine Mol ecular Imaging, vol.2, issue.10, pp.91283-91291, 2002. ,
Tumeurs de la voie excrétrice urinaire. Encyclopé die Médico-Chirurgicale ,
Prognostic significa nce of mo rphologie pararneters in renal cell ca rc inoma Amer ican Journ al of Surgical Path olo gy, pp.655-663, 1982. ,
Observations on the gr owth rate of renal ceII carcinoma, International Journal ofUrology, issue.2, pp.7-8, 1995. ,
Comparison of SUV and Patlak slope for monit oring of cancer therapy using seriai PET scans ,
A tabulate d summary of the FDG PET literature, Journal ofNucIear Medicine, vol.42, pp.1-93, 2001. ,
FDG PET characterization of renal masses: Preliminary experience, Clinical Radiology, vol.52, issue.7, pp.510-515, 1997. ,
DOI : 10.1016/S0009-9260(97)80327-3
Positron emissi on tomography for urological tum ours. BJU international, pp.159-64, 2003. ,
Uptake of 2-Deoxy, 2-(18F) Fluoro-D-Glucose in Bladder Cancer: Animal Localization and Initial Patient Positron Emission Tomography, The Journal of Urology, vol.145, issue.2, pp.279-83, 1991. ,
DOI : 10.1016/S0022-5347(17)38314-3
Bilateral solid multifocal intrarenal and perirenal lesions: Differentiation with ultrasonography, computed tomography and magnetic resonance imaging, Clinical Radiology, vol.50, issue.5, pp.288-294, 1995. ,
DOI : 10.1016/S0009-9260(05)83418-X
Staging of pelvic Iymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2 ,
Caractérisation des masses rénales, Journal de Radiol ogie, vol.83, pp.787-802, 2002. ,
Diagnosis and monitoring of urological tumors using positron emission tomography. European Urolo gy, pp.481-488, 2001. ,
Positron emissi on tomography in urological oncology, Joumal ofUrolo gy, vol.159, issue.2, pp.347-56, 1998. ,
Diagnostic role of [F-18]-FDG positron emissi on tomography in restaging renal cell carcinoma, Clinical Nephrology, vol.60, issue.6, pp.39-44, 2003. ,
Complete radiological and metabolic response of metastatic rena l cell carcinoma to SU541 6 (semaxanib) in a patient with probable von Hippel-Lindau syndrome. Urolo gie Oncolo gy, pp.193-199, 2004. ,
The interest of PET (Positron Emission Tomography) for urothelial tumors. Archives Espagnoles d'Urologie, ApL, vol.57, issue.3, pp.337-384, 2004. ,
Clinical use of fluorodeoxygluc ose F 18 positron emission tomography for detect ion of renal cell carcin oma, Joumal ofUrology, vol.171, issue.5, pp.1806-1815, 2004. ,
Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]flu oro-Dglucose (FDG) in patients with renal cell carcin oma (preliminary report) ,
Preoperative lymph node staging in patients with kidney and urinary bladder neoplasm ,
A primary carcin oid tumor of the kidney : a case report and review of the literature. Abdominal Imaging, pp.464-471, 1996. ,
Cancer du rein. Encyclopédie Médico-Chirurgicale, pp.96-97 ,
URL : https://hal.archives-ouvertes.fr/inserm-00325579
Uptake of cis-4-[18F]fluoro-L-pr oline in urologie tumors, Journal of Nucl ear Medicine, vol.42, issue.5, pp.752-756, 2001. ,
Bacharach SL Parametric images of blood flow in oncology PET studies using [15 0 ] water, Journal of Nuclear Medicine, vol.41, issue.11, pp.1784-92, 2000. ,
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor., American Journal of Roentgenology, vol.169, issue.4, pp.1049-50, 1997. ,
DOI : 10.2214/ajr.169.4.9308463
7. Survey of Results of Whole Body Imaging Using the PET/CT at the University of Pittsburgh Medical Center PET Facility, Clinical Positron Imaging, vol.3, issue.4, p.161, 2000. ,
DOI : 10.1016/S1095-0397(00)00073-X
URL : https://hal.archives-ouvertes.fr/in2p3-00783343
Positron emission tomography in prostate and renal cell carcinoma, Current Opinion in Urology, vol.12, issue.5, pp.381-386, 2002. ,
DOI : 10.1097/00042307-200209000-00003
Guidelines on Renal Cell Cancer, European Urology, vol.40, issue.3, pp.252-255, 2001. ,
DOI : 10.1159/000049783
Récidives et disséminations métastatiques du cancer du rein cliniques et implications en imagerie, Journal of Radiology, vol.84, pp.275-284, 2003. ,
Correlati on between visualization of primary re nal cancer by FDG-PET and histopathological fin dings, Journal of Nuclear Medicine, p.3764, 1996. ,
Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer, International Journal of Urology, vol.37, issue.1, pp.15-23, 2002. ,
DOI : 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.3.CO;2-#
La tomographie par émission de positons aux [18F]-Fluoro -2-desoxyglucose : revue de la littérature et de nos résultats dans les cancers extrapulmonaires, Médecine Nucléaire, vol.23, pp.151-160, 1999. ,
Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera, Journal ofNuclear Medicine, vol.41, issue.1, pp.78-84, 2000. ,
Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat ,
Intramedullary spinal cord metastasis from renal cell carcin oma: detecti on by positron emissi on tomography. Clincal Nuclear Medicine, pp.837-846, 2001. ,
CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA, The Journal of Urology, vol.166, issue.3, pp.825-855, 2001. ,
DOI : 10.1016/S0022-5347(05)65845-4
Cancer incidence and mortality in France over the peri od 1978-2 000. Revue d'Epidémiolo gie et de, Santé Publique, vol.5, issue.1, pp.13-30, 2003. ,
Bilan d'extension et surveillance des tumeurs malignes du rein, Journal of Radiolo, vol.83, pp.805-822, 2002. ,
Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.20, issue.5, pp.1053-60, 1991. ,
DOI : 10.1016/0360-3016(91)90204-H
The usefulness of F-18 deoxyglucose wholebody positron emission tomography (PET) for re-staging of renal cell cancer, Clinical Nephrology, vol.57, issue.01, pp.56-62, 2002. ,
DOI : 10.5414/CNP57056
Tumeurs de la voie excrétrice supérieure. Revue du Praticien, pp.369-401, 1997. ,
Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan, Urology, vol.55, issue.2, p.286, 2000. ,
DOI : 10.1016/S0090-4295(99)00409-4
Positron emission tomography in urologie oncology. Cancer Contro l, pp.335-377, 2002. ,
RE: CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA, The Journal of Urology, vol.168, issue.5, pp.2127-2135, 2002. ,
DOI : 10.1016/S0022-5347(05)64320-0
PET FDG Studies of Wilms Tumors, Journal of Pediatric Hematology/Oncology, vol.19, issue.4, pp.334-342, 1997. ,
DOI : 10.1097/00043426-199707000-00012
Imaging of Renal Cancer Using Positron Emission Tomography with 2-Deoxy-2-(18F)-Fluoro-D-Glucose: Pilot Animal and Human Studies, The Journal of Urology, vol.146, issue.6, pp.1470-1474 ,
DOI : 10.1016/S0022-5347(17)38141-7
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xen ografts. Feasibility studies for cancer imaging with positron-emission tomography. Cancer, pp.1544-50, 1991. ,
A case of renal pelvic tumor visualized by18F-FDG-PET imaging, Annals of Nuclear Medicine, vol.44, issue.2, pp.161-164, 2004. ,
DOI : 10.2214/ajr.155.4.2119098
Nierenzellkarzinom-Metastase in einem mikrofollikularen Adenom der Schilddruse, Acta Medica Austriaca, vol.30, issue.4, pp.141-143, 2002. ,
DOI : 10.1080/003655999750016014
Comparing whole body 18F-2-deoxyglucose positron ennssion tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas -a preliminary report, Journal of cancer research and clinical Onco logy, vol.128, issue.9, pp.503-509, 2002. ,
Cancer Screening with Whole-Body FDG PET ,
DOI : 10.1007/978-3-642-60010-4_6
Novak-Hofer 1. Targeting of renal carcin oma with 67/64Cu-Iabeled anti-LI-CAM antibody chCE7: selection of copper ligands and PET imaging. Nuc1ear Medicine Biolo gy, pp.417-444, 2003. ,
Standardized uptake value as an unreliable index of renal disease on fluorodeoxygluc ose PET imaging. Clinical Nuc1ear Medicin e, pp.358-60, 2000. ,
Horseshoe kidney on FDG positron emission tom ographie imaging is easily confused with malignancy. Clinical Nuc1ear Medicin e, pp.35-36, 2001. ,
LABAZl: A metastatic tumor model for renal cell carcin oma express ing the carbonic anhydrase type 9 tumor antigen. Cancer Research, pp.4952-4961, 2003. ,